SWEDISH EDMONDS — History
CCN 500026 | 3-year financial timeline | COVID resilience: 74/100
🛡️ Public data only — no PHI permitted on this instance.
$245M
Latest Revenue (FY2022)
+8.5%
Revenue CAGR (3yr)
-31.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $208M | $246M | $245M | -0.6% | +8.5% |
| Operating Expenses | $289M | $302M | $321M | +6.3% | +5.4% |
| Operating Margin | -39.1% | -22.9% | -31.3% | -37.0% | +0.0% |
| Net Income | $-81M | $-56M | $-77M | -36.3% | +0.0% |
| Licensed Beds | 188 | 188 | 188 | +0.0% | +0.0% |
| Total Patient Days | 45,540 | 49,318 | 50,300 | +2.0% | +5.1% |
| Medicare Day % | 26% | 25% | 24% | -5.8% | -5.5% |
| Medicaid Day % | 2% | 2% | 3% | +18.4% | +8.5% |
COVID Impact & Recovery
Resilience Score: 74/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.6% ($208M → $245M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.5%
This Hospital
+7.6%
State Avg
Latest Margin
-31.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $263M | -27.4% |
| FY2024 (proj) | $281M | -23.5% |
| FY2025 (proj) | $300M | -19.6% |